Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019
Baoxia Gu, Xiaogai Shang, Mengqing Yan, et al.
Gynecologic Oncology (2021) Vol. 161, Iss. 2, pp. 573-580
Closed Access | Times Cited: 216

Showing 1-25 of 216 citing articles:

Endometrial cancer
Emma J. Crosbie, Sarah Kitson, Jessica N. McAlpine, et al.
The Lancet (2022) Vol. 399, Iss. 10333, pp. 1412-1428
Open Access | Times Cited: 759
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 23, pp. 2145-2158
Open Access | Times Cited: 489
Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives
Ilaria Cuccu, Ottavia D’Oria, Ludovica Sgamba, et al.
Healthcare (2023) Vol. 11, Iss. 4, pp. 571-571
Open Access | Times Cited: 55
Novel Insights into Molecular Mechanisms of Endometrial Diseases
Tullio Golia D’Augè, Ilaria Cuccu, Giusi Santangelo, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 499-499
Open Access | Times Cited: 55
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
Amy Jamieson, Jutta Huvila, Derek S. Chiu, et al.
Modern Pathology (2023) Vol. 36, Iss. 4, pp. 100085-100085
Open Access | Times Cited: 53
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
M.A. Powell, Line Bjørge, Lyndsay Willmott, et al.
Annals of Oncology (2024) Vol. 35, Iss. 8, pp. 728-738
Open Access | Times Cited: 27
Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment
Holly Baker‐Rand, Sarah Kitson
Cancers (2024) Vol. 16, Iss. 5, pp. 1028-1028
Open Access | Times Cited: 22
FIGO 2023 staging system predicts not only survival outcome but also recurrence pattern in corpus-confined endometrial cancer patients
Hua-Hsi Wu, Hung-Tse Chou, Shih-Yao Lin, et al.
Taiwanese Journal of Obstetrics and Gynecology (2025) Vol. 64, Iss. 1, pp. 76-81
Open Access | Times Cited: 3
Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers
Mihan Lee, Pamela Causa Andrieu, Stéphanie Nougaret, et al.
American Journal of Roentgenology (2025), pp. 1-16
Closed Access | Times Cited: 2
The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer
Amy Jamieson, Tjalling Bosse, Jessica N. McAlpine
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 72
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases
Amy Jamieson, Emily F. Thompson, Jutta Huvila, et al.
Gynecologic Oncology (2022) Vol. 165, Iss. 2, pp. 376-384
Closed Access | Times Cited: 44
Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice
Amy Jamieson, Jessica N. McAlpine
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 2, pp. 210-216
Closed Access | Times Cited: 37
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 22, pp. 4564-4574
Open Access | Times Cited: 35
Construction of a prognostic model of luteolin for endometrial carcinoma.
Junde Zhao, Wenjian Jiao, Xiaohui Sui, et al.
PubMed (2023) Vol. 15, Iss. 3, pp. 2122-2139
Closed Access | Times Cited: 30
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer
Calen Kucera, Chunqiao Tian, Christopher M. Tarney, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e238437-e238437
Open Access | Times Cited: 29
Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer
Sushmita Gordhandas, William A. Zammarrelli, Eric Rios‐Doria, et al.
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 2, pp. 217-226
Open Access | Times Cited: 26
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
Amy Jamieson, Jutta Huvila, Samuel Leung, et al.
Gynecologic Oncology (2023) Vol. 170, pp. 282-289
Closed Access | Times Cited: 23
2023 FIGO staging system for endometrial cancer: The evolution of the revolution
David K. Gaffney, Xavier Matías‐Guiu, David G. Mutch, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 245-253
Closed Access | Times Cited: 12
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies
Fernando O. Recio, Carly Bess Scalise, Paul Loar, et al.
Gynecologic Oncology (2024) Vol. 182, pp. 63-69
Open Access | Times Cited: 9
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup
Carien L. Creutzberg, Jae‐Weon Kim, Gemma Eminowicz, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 9, pp. e420-e431
Closed Access | Times Cited: 9
Identification and validation of the important role of KIF11 in the development and progression of endometrial cancer
Biying Wang, Lunmin Bao, Xiaoduo Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
Comparison of laparoscopic vs. robotic sentinel lymph node mapping and biopsy in endometrial cancer
Harrison Odgers, Angela E. Lin, Trevor Tejada‐Berges
Journal of Robotic Surgery (2025) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer
Sylvie Streel, Alixe Salmon, Adriane Dheur, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4866-4866
Open Access | Times Cited: 19
Pyroptosis and inflammasomes in cancer and inflammation
Jie‐Lin Wang, Shengni Hua, Hai‐Juan Bao, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top